000			01500nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aBiomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
546			_aEnglish[eng]
650			_apharmacogenomics||NGS variants||personalized medicine||FSHR||personalized drug therapy||hedgehog-interacting protein||impaired fasting glucose||impaired glucose tolerance||newly diagnosed diabetes||normal glucose tolerance||inflammatory bowel disease||ulcerative colitis||Crohn’s disease||extracellular matrix components||hyaluronan||inflammatory bowel diseases (IBD)||Crohn’s disease (CD)||ulcerative colitis (UC)||sulfated glycosaminoglycans (sGAG)||hyaluronan (HA)||soluble part of syndecan-1 (sCD138)||microRNA||cardiovascular disease||diabetes||mortality||antiplatelet therapy||platelet reactivity||Let-7e||miR-126||miR-223||miR-125a-3p||CCL11||CCL24||CCL26||CCR3||CRC||adiponectin||adipokines||rheumatology||obesity||overweight||case control study||rheumatoid arthritis||TNF-α inhibitors||bone turnover markers||PINP||PICP||NTX-I||CTX-I||RANKL/OPG||ovarian cancer||interleukin 21||interleukin 22||lymphocytes||macrophages||dendritic cells||innate lymphoid cells||breast cancer||extracellular matrix||proteins||tumorigenesis||tumor microenvironment
700			_aKomosinska-Vassev, Katarzyna||Olczyk, Pawel
856			_uhttps://mdpi.com/books/pdfview/book/5293
942			_cEB
999			_c8891 _d8891